The future of GLP-1 research As GLP-1s continue to reshape the treatment of type 2 diabetes and obesity (along with an expanding list of potential indications), real-world evidence will be essential for optimizing their use, ensuring access, and tailoring treatments to the individual needs of patients
In animal models, this pathway has been proposed as a contributor to observed changes in tissue vascularization at injury sites
Heres what we know so far: The monthly price of these drugs is reduced to about US $350 when purchased through the relevant program
Despite label updates over time for other safety concerns, including ileus and risks associated with anesthesia, the lawsuit alleges that Novo Nordisk failed to disclose the risk of NAION
In CVD, the superoxide anion interacts with the nitric oxide free radical to generate peroxynitrite, which interrupts cardiovascular function